Which vein is safer for chemotherapy ports? a trial aims to settle the debate
NCT ID NCT03945045
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial compares two common methods for placing a totally implantable vascular access device (TIVAD), a port used for chemotherapy and other treatments in cancer patients. Researchers are randomly assigning patients to have the port inserted via either the internal jugular vein (neck) or the subclavian vein (chest). The goal is to see which approach leads to fewer complications, such as blood clots, infections, or device malfunctions, over two years of follow-up.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a procedure comparing two vein approaches (internal jugular vein vs. subclavian vein) for implanting a totally implantable vascular access device (TIVAD)
- What this could lead to
- If one approach proves safer, it could become the standard method for placing long-term central lines in cancer patients, reducing complications like blood clots and infections.
- What could go wrong
- This is a single-center trial with 240 patients, so results may not apply to all settings. The study focuses on short-term complications and does not address long-term device performance beyond two years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?